Commenting today on the Centers for Medicare & Medicaid Services’ proposed notice of benefit and payment parameters for 2020, the AHA said it remains committed to ensuring that consumers have access to comprehensive coverage through the health insurance marketplaces. “Comprehensive coverage is critical to patient access to care,” AHA wrote. “We are pleased that the agency did not propose to make immediate policy changes in a number of areas that could reduce consumers’ access to coverage, including changes in policy regarding auto-reenrollment and ‘silver-loading,’ but instead chose to seek comment on potential future actions. We also appreciate the agency’s interest in increased transparency in consumers’ health coverage as the AHA shares in this important goal. CMS has substantial authority to improve and conduct more rigorous oversight of both provider networks and directories to facilitate consumer shopping and avoid surprise medical bills resulting from unanticipated gaps in coverage. However, we are concerned that several of the provisions could result in a loss of coverage or the erosion of key consumer protections.”

Related News Articles

Blog
Public
The health care field has entered a period of disruption, from sweeping coverage changes to the rise of artificial intelligence (AI)-enabled tools. The…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
A Health Affairs study published Nov. 3 examined an increase in states banning prior authorizations in private insurance plans for opioid use disorder…
Headline
The AHA collaborated with LCMC Health in New Orleans to spotlight innovative efforts that extend care beyond hospital walls. LCMC Health supports families…
Headline
The AHA has released a social media toolkit with sample posts and graphics encouraging people to sign up for 2026 health coverage via the Health Insurance…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…